Skip navigation View an alternate layout of this website with limited styles and no horizontal scrolling
Menu

Randomized Trial on the Influence of the Length of Two Insulin Pen Needles on Glycemic Control and Patient Preference in Obese Patients With Diabetes

By Kreugel, Gillian; Keers, Joost C.; Kerstens, Michiel N.; Wolffenbuttel, Bruce H.R.; Diabetes Technology & Therapeutics, Volume 13, Number 7, pages 737-741
Publication Date: 2011

Study determined the influence of needle length for insulin administration on metabolic control and patient preference in obese patients with diabetes mellitus. Participants were 130 insulin-treated type 1 and type 2 diabetes patients with a mean age of 60.5 years and a body mass index of 30 kilograms per square meter or higher, 56 of whom were women and 126 of whom completed the study. Participants were randomized into two groups. Group A started using a 31 gauge, 5 millimeter insulin pen needle for 3 consecutive months, after which they switched to a 31 gauge, 8 millimeter needle for another 3 months. Group B used these two different needles in reverse order. Hemoglobin A1c (A1C), fructosamine, and 1,5-anhydroglucitol were measured, and self reported side effects and patient preference were recorded. No within-group changes were observed with respect to A1C, serum fructosamine, 1,5-anhydroglucitol, hypoglycemic events, bruising, and pain. When data of all 126 participants were pooled, there was a small but statistically significant difference of A1C of 0.12 percent in favor of the 5 millimeter needle. Patients reported less bleeding with the 5 millimeter needle and less insulin leakage from the skin with the 8 millimeter needle. There were no significant differences in user preference, with 46 percent of participants preferring the 5 millimeter needle, 41 percent the 8 millimeter needle, and 13 indicating no length preference. The authors conclude that contrary to some patient instruction information, the 5 millimeter needles can be safely used for insulin injections in obese patients with diabetes mellitus.
Published by: Mary Ann Liebert Publishers, Incorporated   (Website:http://www.liebertpub.com)

Link to text: http://www.liebertonline.com/doi/full/10.1089/dia.2011.0010

AbleData, 8630 Fenton Street, Suite 930, Silver Spring, MD 20910. 1-800-227-0216.
Maintained for the National Institute on Disability and Rehabilitation Research of the U.S. Dept. of Education
by ICF Macro under Contract No. ED-04-CO-0018/0007.

The records in AbleData are provided for information purposes only. Neither the U.S. Department of Education nor ICF Macro has examined, reviewed, or tested any product, device, or information contained in AbleData. The Department and ICF Macro make no endorsement, representation, or warranty express or implied as to any product, device, or information set forth in AbleData. The views expressed on this site do not necessarily represent the opinions of the Department of Education, the National Institute on Disability and Rehabilitation Research, or ICF Macro.